Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6B
|
pubmed:dateCreated |
1993-4-9
|
pubmed:abstractText |
The erbB2-encoded protein p185 was determined in 130 breast cancer specimens and in 29 non-malignant breast tissues using a recently available ELISA method. The assay showed good characteristics of precision and accuracy. In the non-malignant tissue p185 concentrations were normally distributed and directly correlated with estrogen receptors (ER) and progesterone receptors (PR). In cancer tissue p185 showed higher concentrations than in non-malignant tissue. No relationships were found between p185 and the main clinical and pathological parameters, except that a direct association with nuclear grade was found. We have categorized the breast cancer samples according to p185 concentrations as p185-negative (concentrations lower than the higher non-malignant tissue) and p185-positive. Our data suggested a different behaviour of p185 in samples with low or high p185 concentrations. Indeed, in p185-negative samples the concentrations were directly correlated with both ER and PR. Conversely, p185-positive samples were directly associated with node status and pT, and inversely associated with ER and PR.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Proto-Oncogene Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
pubmed:status |
MEDLINE
|
pubmed:issn |
0250-7005
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2005-10
|
pubmed:dateRevised |
2009-11-19
|
pubmed:meshHeading |
pubmed-meshheading:1363513-Adult,
pubmed-meshheading:1363513-Aged,
pubmed-meshheading:1363513-Breast,
pubmed-meshheading:1363513-Breast Neoplasms,
pubmed-meshheading:1363513-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:1363513-Female,
pubmed-meshheading:1363513-Humans,
pubmed-meshheading:1363513-Middle Aged,
pubmed-meshheading:1363513-Proto-Oncogene Proteins,
pubmed-meshheading:1363513-Receptor, erbB-2,
pubmed-meshheading:1363513-Receptors, Estrogen,
pubmed-meshheading:1363513-Receptors, Progesterone,
pubmed-meshheading:1363513-Tumor Markers, Biological
|
pubmed:articleTitle |
Immunoenzymatic assay of erbB2 protein in cancer and non-malignant breast tissue. Relationships with clinical and biochemical parameters.
|
pubmed:affiliation |
Center for the Study of Biological Markers of Malignancy, Regional General Hospital, Venice, Italy.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|